ArticleProstate cancer and prostatic diseases2026

Ultrasound echogenicity is complementary to PI-RADS for risk stratification of clinically significant prostate cancer.

Garret Wegner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.